Aveanna Healthcare Holdings Inc (AVAH)
NASDAQ:AVAH
Top Page
Aveanna Healthcare Holdings
(NASDAQ:AVAH)
Select Model
Select Model
Rating:53Neutral
Price Target:
$6.50
▼(-1.81% Downside)
Action:ReiteratedDate:03/20/26
The score is driven primarily by improving operating performance and constructive guidance, tempered by high leverage and limited balance-sheet cushion. Technical signals are notably weak (downtrend with negative momentum), while valuation is supportive due to the low P/E.
Positive Factors
Preferred-payer strategy & national scale
Aveanna’s focused push to convert volume to preferred-payer contracts across a national footprint raises revenue predictability and improves realized rates. Preferred relationships reduce authorization friction, boost margins over time, and support durable payer diversification that reinforces competitive positioning.
Negative Factors
High leverage and thin equity base
Very high debt relative to a small equity base materially reduces financial flexibility and raises refinancing risk. Even with improving cash flow, the capital structure constrains downside resiliency and makes the company more sensitive to cyclical shocks or weaker reimbursement outcomes over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Preferred-payer strategy & national scale
Aveanna’s focused push to convert volume to preferred-payer contracts across a national footprint raises revenue predictability and improves realized rates. Preferred relationships reduce authorization friction, boost margins over time, and support durable payer diversification that reinforces competitive positioning.
Read all positive factors
Aveanna Healthcare Holdings (AVAH) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.44B
Dividend YieldN/A
Average Volume (3M)1.28M
Price to Earnings (P/E)2.3
Beta (1Y)1.28
Revenue Growth15.48%
EPS GrowthN/A
CountryUS
Employees33,500
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.17
Shares Outstanding217,510,040
10 Day Avg. Volume1,461,625
30 Day Avg. Volume1,284,052
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)8.46
Price to Sales (P/S)0.68
P/FCF Ratio14.33
Enterprise Value/Market Cap1.80
Enterprise Value/Revenue1.06
Enterprise Value/Gross Profit3.22
Enterprise Value/Ebitda9.43
Forecast
1Y Price Target
$9.63Price Target Upside45.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)0.62
Revenue Forecast (FY)$2.56B
Aveanna Healthcare Holdings Business Overview & Revenue Model
Company Description
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centere...
How the Company Makes Money
Aveanna primarily makes money by delivering reimbursable healthcare services and billing third-party payors for those services. The company’s main revenue streams include: (1) Private Duty Services: Ongoing in-home nursing and aide services, with ...
Aveanna Healthcare Holdings Earnings Call Summary
Earnings Call Date:Mar 19, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Positive
The call presented strong operational and financial momentum: double-digit top-line growth, substantial YoY adjusted EBITDA expansion, improved margins in key segments, robust liquidity and free cash flow, and meaningful progress on preferred payer strategies and targeted M&A (Family First). Offsetting risks include non-recurring benefits (53rd week and reserve release), continued caregiver labor and wage pressure, California reimbursement uncertainty, Medical Solutions near-term normalization, and material variable-rate debt (largely hedged). Management provided prudent 2026 guidance that normalizes the strong 2025 results and emphasized continued execution on preferred payer expansion, margin stabilization, and selective acquisitions.Positive Updates
Strong Top-Line Growth
Q4 revenue of $662.5M, up 27.4% year-over-year; full-year 2025 revenue of $2.433B, up 20.2% versus prior year (results benefitted from a 53rd week).
Negative Updates
One-Time / Non-Recurring Boosts
Q4 and full-year results benefited from a 53rd week (extra week of activity) and Medical Solutions recorded a reserve release that added ~$2.5M–$3M to revenue/EBITDA in Q4; Medical Solutions margins expected to normalize to 43%–45% in Q1.
Read all updates
Q4-2025 Updates
Positive
Negative
Strong Top-Line Growth
Q4 revenue of $662.5M, up 27.4% year-over-year; full-year 2025 revenue of $2.433B, up 20.2% versus prior year (results benefitted from a 53rd week).
Read all positive updates
Company Guidance
Aveanna guided full‑year 2026 revenue of $2.54–$2.56 billion and adjusted EBITDA of $318–$322 million (guidance excludes the Family First acquisition); Family First is expected to close in Q2 for $175.5 million (~7.5x post‑synergy EBITDA, ~$120 million revenue) funded with cash and the securitization facility. Management expects to end 2026 flat to slightly lower on leverage (around 4x), to generate similar free cash flow to 2025’s $131 million, and to maintain strong liquidity (Q4 liquidity was $529 million — cash $193 million, $110 million securitization availability, $226 million revolver availability; Q4 letters of credit $24.5 million). Operational targets baked into the outlook include adding 8 PDS preferred‑payer agreements to reach 38 (Q4 PDS preferred volume ~57% expected to reach low‑60% in 2026), achieving home‑health episodic mix >75% and growing preferred payers from 45 toward >50, expanding medical solutions preferred payers from 18 to ~25 (with medical solutions gross margins normalizing to ~43–45%), and securing modest government rate wins (roughly 6–8 state actions in 2026, characterized as cost‑of‑living increases of ~1%–5% each); management also noted Q1 is seasonally the weakest cash quarter and 2025 benefited from a 53rd week.Aveanna Healthcare Holdings Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
34
Negative
Cash Flow
58
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.43B | 2.02B | 1.90B | 1.79B | 1.68B |
| Gross Profit | 805.15M | 635.54M | 595.43M | 553.23M | 542.40M |
| EBITDA | 274.56M | 187.38M | 39.17M | -525.06M | -17.95M |
| Net Income | 225.03M | -10.93M | -134.52M | -662.03M | -117.04M |
Balance Sheet | |||||
| Total Assets | 2.03B | 1.66B | 1.61B | 1.71B | 2.33B |
| Cash, Cash Equivalents and Short-Term Investments | 193.26M | 84.29M | 43.94M | 19.22M | 30.49M |
| Total Debt | 1.34B | 1.50B | 1.50B | 1.36B | 1.30B |
| Total Liabilities | 1.83B | 1.79B | 1.74B | 1.72B | 1.70B |
| Stockholders Equity | 194.46M | -122.09M | -127.44M | -4.17M | 637.95M |
Cash Flow | |||||
| Free Cash Flow | 114.79M | 26.32M | 16.56M | -60.41M | -27.30M |
| Operating Cash Flow | 122.24M | 32.64M | 22.67M | -48.40M | -11.35M |
| Investing Cash Flow | -22.30M | -6.32M | -8.79M | -25.29M | -681.83M |
| Financing Cash Flow | 5.41M | 14.03M | 10.85M | 62.42M | 586.33M |
Aveanna Healthcare Holdings Technical Analysis
Negative
6.62
Price Trends
7.72
Negative
8.29
Negative
7.52
Negative
Market Momentum
-0.30
Positive
36.73
Neutral
55.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVAH, the sentiment is Negative. The current price of 6.62 is below the 20-day moving average (MA) of 7.02, below the 50-day MA of 7.72, and below the 200-day MA of 7.52, indicating a bearish trend. The MACD of -0.30 indicates Positive momentum. The RSI at 36.73 is Neutral, neither overbought nor oversold. The STOCH value of 55.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AVAH.
Aveanna Healthcare Holdings Risk Analysis
Aveanna Healthcare Holdings disclosed 56 risk factors in its most recent earnings report. Aveanna Healthcare Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Aveanna Healthcare Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $2.51B | 17.67 | 11.57% | 1.80% | 23.74% | -18.99% | |
75 Outperform | $1.85B | 20.66 | 9.24% | ― | 18.77% | 6.88% | |
72 Outperform | $1.08B | 28.23 | 10.87% | ― | 29.89% | 10.33% | |
62 Neutral | $2.02B | 12.54 | 5.57% | 1.69% | -22.96% | -59.35% | |
58 Neutral | $3.29B | -9.62 | -523.78% | ― | 3.93% | -42.22% | |
53 Neutral | $1.44B | 2.30 | 953.09% | ― | 15.48% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
AVAH
Aveanna Healthcare Holdings
6.62
1.24
23.05%
ADUS
Addus Homecare
99.32
3.17
3.30%
BKD
Brookdale Senior Living
13.82
7.93
134.63%
NHC
National Healthcare
161.42
71.02
78.56%
SEM
Select Medical
16.29
-0.37
-2.19%
PNTG
Pennant Group
31.11
6.31
25.44%
Aveanna Healthcare Holdings Corporate Events
Business Operations and StrategyFinancial Disclosures
Aveanna Issues 2026 Guidance and Growth Outlook
Positive
Mar 20, 2026
Aveanna Healthcare Holdings Inc., a large U.S. home healthcare provider, operates 366 locations in 38 states, employs roughly 29,000 caregivers, and delivered 46.1 million homecare hours in fiscal 2025. The company, which reported a 33.3% gross ma...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Aveanna Healthcare Posts Strong Q4, Affirms 2026 Outlook
Positive
Mar 19, 2026
Aveanna Healthcare reported strong fourth-quarter and full-year 2025 results on March 19, 2026, with Q4 revenue rising 27.4% year over year to $662.5 million and net income jumping to $178.8 million, while adjusted EBITDA grew 54.0% to $85.0 milli...
Business Operations and StrategyM&A Transactions
Aveanna to Acquire Family First Homecare in Cash Deal
Positive
Mar 12, 2026
On March 9, 2026, Aveanna subsidiary Pediatric Services of America, LLC agreed to acquire all membership interests of Family First Holding, LLC, a multi-state pediatric home care provider operating as Family First Homecare, for $175.5 million in c...
Executive/Board Changes
Aveanna Healthcare Announces Board Director Robert Williams Resignation
Neutral
Feb 27, 2026
On February 27, 2026, Aveanna Healthcare Holdings Inc. announced that Class I director Robert M. Williams, Jr. resigned from its Board of Directors, effective immediately. The company stated that his departure was not due to any disagreement regar...
Business Operations and StrategyExecutive/Board Changes
Aveanna Healthcare updates executive contracts, boosts leadership incentives
Positive
Feb 20, 2026
On February 17, 2026, Aveanna Healthcare, LLC entered into new employment agreements with President and CEO Jeff Shaner, CFO Matthew Buckhalter, and Chief Legal Officer and Secretary Jerry Perchik, replacing their prior contracts and setting updat...
Business Operations and StrategyFinancial Disclosures
Aveanna Healthcare Raises 2025 Outlook, Issues 2026 Guidance
Positive
Jan 14, 2026
On January 14, 2026, Aveanna Healthcare Holdings updated its full-year 2025 guidance for the fiscal year ended January 3, 2026, raising expected revenue to a range of $2.425 billion to $2.445 billion from prior guidance of more than $2.375 billion...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.